Unfair participant selection in clinical trials is addressed by a new computer model.

Published Date: 26 Apr 2023

The target population typically has better health than participants in health research studies, such as cancer screening trials (the "healthy volunteer" effect).

Read Full News

Latest News

Cigna Invests $100 Million in New AI-powered Specialty Pharmacy Program

Cigna said on Wednesday its health services unit Evernorth has launched a new ⁠AI-powered specialty pharmacy program to reduce the time it takes to process prescriptions and...

Resident Doctors in England Vote for UK Government's Pay Offer, Ending Strikes

Resident doctors in England have voted to accept the government's latest pay and job offer, their ⁠union said on Monday, bringing an end to a long-running industrial dispute...

Democratic-led States Sue Over Trump Administration's Medicaid Work Requirement Rule

A coalition of Democratic-led states sued on Monday to block a Trump administration rule implementing new work requirements for Medicaid recipients, ⁠arguing it unlawfully...

Trump Cuts New York Funding for Medicaid Fraud Unit

The Trump administration said on Tuesday it would cut off funding to ⁠New York's Medicaid fraud unit, accusing it of underperforming in a move that could jeopardize the...

Europe Must Rethink Medicine Pricing or Risk Losing Investment

Europe will need to rethink how it values and pays for innovative ⁠medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.

Medicare AI Creates Errors and Delays for Patients, Doctors

Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Latest News

Cigna said on Wednesday its health services unit Evernorth has launched a new ⁠AI-powered specialty pharmacy program to reduce the time it takes to process prescriptions and...

Resident doctors in England have voted to accept the government's latest pay and job offer, their ⁠union said on Monday, bringing an end to a long-running industrial dispute...

A coalition of Democratic-led states sued on Monday to block a Trump administration rule implementing new work requirements for Medicaid recipients, ⁠arguing it unlawfully...

The Trump administration said on Tuesday it would cut off funding to ⁠New York's Medicaid fraud unit, accusing it of underperforming in a move that could jeopardize the...

Europe will need to rethink how it values and pays for innovative ⁠medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.

Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.

News All Time

Delays in Visa Program Threaten Hundreds of Doctors

Prolonged HHS J-1 waiver backlogs leave hundreds of foreign-trained doctors facing departure this summer, threatening care in underserved areas, immigration attorneys warn.

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Europe Risks Falling Behind in Medicine Race, Roche CEO

Europe risks falling behind the US and China in pharma innovation because of bureaucracy and government policies threatening ⁠jobs, Roche CEO Thomas Schinecker warns.

US Health Regulators to Speed Up Medicare Device Coverage

U.S. health regulators announced a new program to speed up Medicare coverage for certain medical devices on ⁠Thursday, saying it would cut reimbursement timelines to as...

Germany Risks Missing Out on New Drugs, AstraZeneca CEO Says

AstraZeneca's CEO said Germany risks missing out on new drugs that ⁠the drugmaker plans to launch if the nation sticks with plans to keep pharmaceutical spending in check.

U.S. to Ask States to Revalidate "high-risk" Medicaid Providers

Mehmet Oz, who heads the agency that runs the U.S. Medicare and ⁠Medicaid healthcare programs, said on Tuesday the Trump administration plans to ask all ⁠50 states to...

US FDA Warns Medline Over Defective Heart Procedure Syringes

The U.S. Food and Drug Administration has told medical device maker Medline that its syringes used in heart procedures ⁠are defective and warned the company of penal actions.

Swiss Industry Body Says US Tariffs on Pharmaceuticals Will Harm Patients

U.S. President Donald Trump's 100% tariffs on the pharmaceutical industry threaten global production, ⁠supply chains and ultimately will harm patients, Switzerland's...

The ACA Subsidy Gap and Its Toll on Primary Care

When the ACA’s subsidy credits expired at the end of 2025, physicians knew patient volume and overall revenue would tank. How are doctors faring?

Karyopharm's Drug Meets One Of Two Goals in Blood Cancer Trial

Karyopharm Therapeutics said on Tuesday its therapy led to significant reduction in spleen size in a late-stage ⁠study of patients with a rare blood cancer, meeting only one...

Match Day Traditions Are Evolving

Opening the Match Day envelope with other med students is a once-in-a-lifetime event that most students want to celebrate together, but private options are good too.

Getting The Right Signal: Does Program Signaling Work?

Designed to curb application inflation and help mid-tier candidates, signaling is now the ‘make-or-break’ metric for a match. But is it working or creating new problems?

US Proposes Easing Limits on Cancer-causing Gas Used to Clean Medical Devices

The Trump administration is proposing to lift some limits on the use of ethylene oxide, a carcinogenic gas used ⁠for sterilization, saying previous constraints imposed under...

BMA Warns Scottish Medical Schools ‘Beyond Capacity’

Medical student numbers in Scotland have risen 72% since 2015, but teaching capacity and training posts have not kept pace, a BMA report warns.

Federal Loan Caps Will Reduce PA School Applicants

Proposed federal student loan caps will drive students into pricier private loans, or derail their aspirations of becoming PAs, creating professional healthcare shortages.

The Golden Handcuffs of Private Equity

Private equity firms are increasingly buying up smaller medical practices. Sometimes for the better, and sometimes not.

Recommended News For You

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Racial differences seen in epigenetic age acceleration in childhood cancer survivors

The September 2018 issue of Medical Bulletin.

Australian researchers attribute drop in melanoma rates to increasingly diverse population

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

Dual-action mRNA vaccine takes aim at aggressive skin cancer

Recommended Articles For You

Anemia Symptoms: What You Need to Know  

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options  

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances 

Immune Escape Landscapes in Solid Tumors 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

2.

High numbers of rural patients cross state lines for cancer care

3.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

4.

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

5.

Novel biomarkers may improve diagnosis of gallbladder cancer

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care

3.

Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications

4.

The Science Behind Imatinib: How It Targets Cancer Cells 

5.

Progressive Techniques in Oncology in Daily Practice

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot